Català-Moll, F, Blázquez-Bondia, C, Farré-Badia, J, Torres, F, Manzardo, C, Bonfill, E, Curran, A, Domingo, P, Podzamczer, D, Force, L, Falcó, V, Parera, M, Casadellà, M, Miró, JM, Noguera-Julian, M, Paredes, R. Dolutegravir restores gut microbiota in late-stage HIV-1 unlike darunavir: an open-label, randomized clinical trial. Nature Communications. 2026; 17(1)DOI:10.1038/s41467-026-69846-7. PMID:41781390. IF:15.700(Q1/1D).

de Lazzari, E, Negredo, EB, Domingo, P, Tiraboschi, JM, Ribera, E, Abdulghani, N, Alba, V, Fernández-Arroyo, S, Viladés, C, Peraire, J, Gatell, JM, Blanco, JL, Vidal, F, Rull, A, Martinez, E. Multiomics plasma effects of switching from triple antiretroviral regimens to dolutegravir plus lamivudine. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2024; 79(5)DOI:10.1093/jac/dkae083. PMID:38546974. IF:3.600(Q2/3D).

Nomah, DK, Jamarkattel, S, Bruguera, A, Moreno-Fornés, S, Díaz, Y, Alonso, L, Aceitón, J, Llibre, JM, Domingo, P, Saumoy, M, Homar, F, Fanjul, F, Navarro, J, de la Mora, L, Knobel, H, Orti, A, Martin-Iguacel, R, Miró, JM, Casabona, J, Reyes-Urueña, J. Evolving AIDS- and non-AIDS Mortality and Predictors in the PISCIS Cohort of People Living With HIV in Catalonia and the Balearic Islands (Spain), 1998-2020. Open Forum Infectious Diseases. 2024; 11(4)DOI:10.1093/ofid/ofae132. PMID:38560603. IF:3.800(Q1/3D).

Fernandez Montes A., Elez E., de la Haba-Rodriguez J., Paez D., Mendez-Vidal M.J., Felip E., Rodriguez-Lescure A.. Medical oncology workload, workforce census, and needs in Spain: two nationwide studies by the Spanish Society of medical oncology. Clinical & Translational Oncology. 2024; 26DOI:10.1007/s12094-023-03225-2. PMID:37316754. IF:2.500(Q3/6D).